BVS
Bioventus Inc
NASDAQ: BVS · HEALTHCARE · MEDICAL DEVICES
$9.87
+2.07% today
Updated 2026-04-30
Market cap
$682.47M
P/E ratio
30.58
P/S ratio
1.20x
EPS (TTM)
$0.33
Dividend yield
—
52W range
$6 – $11
Volume
0.4M
Bioventus Inc (BVS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.75M | $15.11M | $18.92M | $45.19M | $40.71M | $71.80M | $22.99M | $-13.54M | $15.34M | $38.80M | $73.98M |
| Capital expenditures | $6.36M | $20.83M | $7.44M | $6.06M | $8.34M | $20.67M | $7.37M | $1.48M | $7.36M | $1.01M | $2.56M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $576000.00 | $2.35M | $3.33M | $14.32M | $10.84M | $10.10M | $-4.51M | $17.59M | $2.72M | $10.06M | $12.67M |
| Free cash flow | $-3.61M | $-5.72M | $11.48M | $39.13M | $32.37M | $51.13M | $15.62M | $-15.02M | $7.98M | $37.79M | $71.41M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $2.50M | $2.40M | $1.02M | $7.85M | $9.14M | $19.89M | $367000.00 | $3.35M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $12.60M | — | — | — | — |